Datavault AI Licenses Smart Contract Technology to Wellgistics Health for Pharmacy Network Modernization

Datavault AI (NASDAQ: DVLT) has exclusively licensed its proprietary smart contracts intellectual property to Wellgistics Health (NASDAQ: WGRX) for integration into the PharmacyChain(TM) and EinsteinRx(TM) platforms. This strategic partnership will enable Web 3.0 smart contract functions across Wellgistics' network of more than 6,500 pharmacies, representing a significant advancement in pharmaceutical distribution technology. The integration supports Wellgistics' comprehensive plan to streamline prescription tracking processes while reducing costs traditionally driven by pharmacy benefit managers.

The implementation of Datavault AI's smart contract technology aims to enhance transparency for healthcare payers while modernizing U.S. pharmaceutical distribution through advanced data automation and artificial intelligence integration. This collaboration marks a substantial step toward transforming how prescription medications are tracked, managed, and distributed throughout the healthcare ecosystem. The technology transfer represents a critical milestone in applying Web 3.0 capabilities to real-world healthcare challenges, particularly in the complex pharmaceutical supply chain where efficiency and transparency have long been problematic areas.

Datavault AI's cloud-based platform provides comprehensive solutions with a collaborative focus through its Acoustic Science and Data Science Divisions. The company's technology suite offers completely customizable AI and Machine Learning automation, third-party integration capabilities, detailed analytics, and marketing automation features. The Information Data Exchange(R)(IDE) component enables Digital Twins and licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata objects, fostering responsible AI implementation with integrity.

For investors seeking additional information about Datavault AI, the company maintains its newsroom at https://ibn.fm/DVLT where the latest updates and developments are regularly posted. The licensing agreement represents a significant validation of Datavault AI's intellectual property portfolio and demonstrates the commercial applicability of its Web 3.0 technologies in the healthcare sector. This partnership positions both companies at the forefront of pharmaceutical technology innovation, potentially setting new standards for how prescription medications are managed and distributed across the United States.

The integration of smart contract technology into pharmacy operations addresses several longstanding challenges in pharmaceutical distribution, including prescription verification, supply chain transparency, and cost management. By leveraging Datavault AI's proprietary systems, Wellgistics aims to create a more efficient and accountable pharmaceutical distribution network that benefits pharmacies, payers, and ultimately patients. The scale of this implementation across 6,500 pharmacy locations makes this one of the largest deployments of Web 3.0 technology in the healthcare industry to date.